eLife (Apr 2024)

Statin-mediated reduction in mitochondrial cholesterol primes an anti-inflammatory response in macrophages by upregulating Jmjd3

  • Zeina Salloum,
  • Kristin Dauner,
  • Yun-feng Li,
  • Neha Verma,
  • David Valdivieso-González,
  • Víctor Almendro-Vedia,
  • John D Zhang,
  • Kiran Nakka,
  • Mei Xi Chen,
  • Jeffrey McDonald,
  • Chase D Corley,
  • Alexander Sorisky,
  • Bao-Liang Song,
  • Iván López-Montero,
  • Jie Luo,
  • Jeffrey F Dilworth,
  • Xiaohui Zha

DOI
https://doi.org/10.7554/eLife.85964
Journal volume & issue
Vol. 13

Abstract

Read online

Statins are known to be anti-inflammatory, but the mechanism remains poorly understood. Here, we show that macrophages, either treated with statin in vitro or from statin-treated mice, have reduced cholesterol levels and higher expression of Jmjd3, a H3K27me3 demethylase. We provide evidence that lowering cholesterol levels in macrophages suppresses the adenosine triphosphate (ATP) synthase in the inner mitochondrial membrane and changes the proton gradient in the mitochondria. This activates nuclear factor kappa-B (NF-κB) and Jmjd3 expression, which removes the repressive marker H3K27me3. Accordingly, the epigenome is altered by the cholesterol reduction. When subsequently challenged by the inflammatory stimulus lipopolysaccharide (M1), macrophages, either treated with statins in vitro or isolated from statin-fed mice, express lower levels proinflammatory cytokines than controls, while augmenting anti-inflammatory Il10 expression. On the other hand, when macrophages are alternatively activated by IL-4 (M2), statins promote the expression of Arg1, Ym1, and Mrc1. The enhanced expression is correlated with the statin-induced removal of H3K27me3 from these genes prior to activation. In addition, Jmjd3 and its demethylase activity are necessary for cholesterol to modulate both M1 and M2 activation. We conclude that upregulation of Jmjd3 is a key event for the anti-inflammatory function of statins on macrophages.

Keywords